BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL
12167 results:

  • 1. The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
    Baudewyns A; Guenzel K; Halinski A; Dariane C; Delavar G; Anract J; Barry Delongchamps N; Jabbour T; Bourgeno HA; Lefebvre Y; Ferriero M; Simone G; Fourcade A; Fournier G; Oderda M; Gontero P; Bernal-Gomez A; Mastrorosa A; Roche JB; Zahr RA; Ploussard G; Fiard G; Rysankova K; Bui AP; Taha F; Windisch O; Benamran D; Vlahopoulos L; Assenmacher G; Roumeguère T; Peltier A; Diamand R
    World J Urol; 2024 May; 42(1):322. PubMed ID: 38747982
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
    Quintanilha JCF; Sibley AB; Liu Y; Niedzwiecki D; Halabi S; Rogers L; O'Neil B; Kindler H; Kelly W; Venook A; McLeod HL; Ratain MJ; Nixon AB; Innocenti F; Owzar K
    BMC Genomics; 2024 May; 25(1):473. PubMed ID: 38745123
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Digital Adoption by an Organization Supporting Informal Caregivers During COVID-19 Pandemic Showing Impact on Service Use, Organizational Performance, and Carers' Well-Being: Retrospective Population-Based Database Study With Embedded User Survey.
    Szczepura A; Khan AJ; Wild D; Nelson S; Woodhouse S; Collinson M
    JMIR Aging; 2024 May; 7():e46414. PubMed ID: 38739915
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from prostate cancer Patients.
    Roumeliotou A; Strati A; Chamchougia F; Xagara A; Tserpeli V; Smilkou S; Lagopodi E; Christopoulou A; Kontopodis E; Drositis I; Androulakis N; Georgoulias V; Koinis F; Kotsakis A; Lianidou E; Kallergi G
    Cells; 2024 May; 13(9):. PubMed ID: 38727318
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increasing the radiation-induced cytotoxicity by silver nanoparticles and docetaxel in prostate cancer cells.
    Hatami Zharabad S; Mohammadian M; Zohdi Aghdam R; Hassanzadeh Dizaj M; Behrouzkia Z
    Mol Biol Rep; 2024 May; 51(1):633. PubMed ID: 38724835
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An untargeted analytical workflow based on Kendrick mass defect filtering reveals dysregulations in acylcarnitines in prostate cancer tissue.
    Cerrato A; Aita SE; Biancolillo A; Laganà A; Marini F; Montone CM; Rosati D; Salciccia S; Sciarra A; Taglioni E; Capriotti AL
    Anal Chim Acta; 2024 Jun; 1307():342574. PubMed ID: 38719419
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial.
    Zapatero A; Castro P; Roch M; Carnero PR; Carroceda S; Rosciupchin AES; Hernández SH; Cogorno L; Iturriaga AG; García DB
    Radiat Oncol; 2024 May; 19(1):54. PubMed ID: 38702761
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
    Lokeshwar SD; Ali A; Weiss TR; Reynolds J; Shuch BM; Ferencz T; Kyriakides TC; Mehal WZ; Brito J; Renzulli J; Leapman MS
    BMC Urol; 2024 May; 24(1):102. PubMed ID: 38702664
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. On the necessity of specialized knowledge-based models for SBRT prostate treatments plans.
    Scaggion A; Cavinato S; Dusi F; El Khouzai B; Guida F; Paronetto C; Rossato MA; Sapignoli S; Scott ASA; Sepulcri M; Paiusco M
    Phys Med; 2024 May; 121():103364. PubMed ID: 38701626
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. prostate size ≥ 100 g and its association with long-term outcomes of Retzius-sparing robot-assisted radical prostatectomy.
    Maltzman O; Tappero S; Caviglia A; Palagonia E; Buratto C; Chierigo F; Cellini V; Olivero A; Barbieri M; Secco S; Bocciardi AM; Galfano A; Dell'Oglio P
    World J Urol; 2024 May; 42(1):283. PubMed ID: 38695988
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. prostate biopsy sepsis prevention: external validation of an alcohol needle washing protocol.
    Hiffa A; Chen M; Boghani F; Oberle MD; Reed WC; King SA; De Caro J; Terris MK; Simmons MN; Dykes TE
    World J Urol; 2024 May; 42(1):279. PubMed ID: 38693444
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Plant-Based Diets and Disease Progression in Men With prostate cancer.
    Liu VN; Van Blarigan EL; Zhang L; Graff RE; Loeb S; Langlais CS; Cowan JE; Carroll PR; Chan JM; Kenfield SA
    JAMA Netw Open; 2024 May; 7(5):e249053. PubMed ID: 38691361
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Demographical and Epidemiological Contribution to cancer Incidence in Delhi and Its Trends from 1991-2015.
    Malhotra RK; Manoharan N; Deo SS; Bhatnagar S
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1213-1222. PubMed ID: 38679980
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
    Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
    Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [prostate cancer - a disease in transformation].
    Bratt O
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38661575
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Characterisation of Portuguese radiotherapy departments: Organisation, occupational exposure values and diagnostic reference levels for breast and prostate computed tomography planning.
    Guisantes R; Santos J; Ferreira AJ
    Radiography (Lond); 2024 May; 30(3):932-937. PubMed ID: 38657386
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Skin Changes in Suspected Lyme Disease.
    Vržogić P; Perica A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Antibacterial prophylaxis with fosfomycin at the time of the urethral catheter removal after radical prostatectomy (prospective randomized trial)].
    Veliev E I; Sokolov E A; Metelev A Y; Aliev E N; Polyakova A S; Ivkin E V
    Urologiia; 2024 Mar; (1):35-40. PubMed ID: 38650404
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology.
    Sorce G; Stabile A; Pellegrino F; Mazzone E; Mattei A; Afferi L; Serni S; Minervini A; Roumiguiè M; Malavaud B; Valerio M; Rakauskas A; Marra G; Gontero P; Porpiglia F; Guo H; Zhuang J; Gandaglia G; Montorsi F; Briganti A
    World J Urol; 2024 Apr; 42(1):248. PubMed ID: 38647689
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surgical management of rectal cancer with synchronous treatment of prostate cancer.
    Brière R; Martin AG; Letarte F; Fournier FR; Bouchard P; Drolet S
    Langenbecks Arch Surg; 2024 Apr; 409(1):133. PubMed ID: 38642125
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 609.